Difference in medication trajectories between subgroups of patients with type 2 diabetes.
| dc.rights.license | CC-BY-NC-ND | |
| dc.contributor.advisor | Weir, D.L. | |
| dc.contributor.author | Ha, Kitty | |
| dc.date.accessioned | 2022-09-09T01:02:41Z | |
| dc.date.available | 2022-09-09T01:02:41Z | |
| dc.date.issued | 2022 | |
| dc.identifier.uri | https://studenttheses.uu.nl/handle/20.500.12932/42451 | |
| dc.description.sponsorship | Utrecht University | |
| dc.language.iso | EN | |
| dc.subject | Diabetes is one of the most common chronic non-communicable diseases and most patients with diabetes have multimorbidity. The first step towards understanding how best to optimize drug regimens in diabetes is to understand current trajectories of treatment patterns among this patient population. In this project, medication trajectories for diabetic people with multiple chronic conditions are analysed and specifically the differences in these trajectories between subgroups of patients. | |
| dc.title | Difference in medication trajectories between subgroups of patients with type 2 diabetes. | |
| dc.type.content | Master Thesis | |
| dc.rights.accessrights | Open Access | |
| dc.subject.courseuu | Applied Data Science | |
| dc.thesis.id | 8844 |